Basic Materials -
Chemicals - Specialty - NASDAQ - US
$ 158.1
-2.84 %
$ 5.14 B
Market Cap
40.03
P/E
1. INTRINSIC VALUE
Balance Sheet
Balchem Corporation
| Current Assets | 314 M |
| Cash & Short-Term Investments | 49.5 M |
| Receivables | 120 M |
| Other Current Assets | 145 M |
| Non-Current Assets | 1.26 B |
| Long-Term Investments | 0 |
| PP&E | 299 M |
| Other Non-Current Assets | 962 M |
| Current Liabilities | 158 M |
| Accounts Payable | 54.7 M |
| Short-Term Debt | 6.66 M |
| Other Current Liabilities | 96.3 M |
| Non-Current Liabilities | 268 M |
| Long-Term Debt | 34.1 M |
| Other Non-Current Liabilities | 234 M |
EFFICIENCY
Earnings Waterfall
Balchem Corporation
| Revenue | 954 M |
| Cost Of Revenue | 617 M |
| Gross Profit | 336 M |
| Operating Expenses | 153 M |
| Operating Income | 183 M |
| Other Expenses | 54.4 M |
| Net Income | 128 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Balchem Corporation
| Net Income | 128 M |
| Depreciation & Amortization | 48 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 16.7 M |
| Change in Working Capital | -6.12 M |
| Others | -4.34 M |
| Free Cash Flow | 182 M |
Wall Street Analysts Price Targets
Balchem Corporation
Wall Street analysts predict an average 1-year price target for BCPC of $190 , with forecasts ranging from
a
low of
$190 to a high of $190 .
BCPC Lowest Price Target
Wall Street Target
190 USD
20.18%
BCPC Average Price Target
Wall Street Target
190 USD
20.18%
BCPC Highest Price Target
Wall Street Target
190 USD
20.18%
4. DIVIDEND
ANALYSIS
0.00%
DIVIDEND YIELD
0.87 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Balchem Corporation
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
2.25 M USD 2
9-12 MONTHS
1.06 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Blachem (BCPC) Upgraded to Strong Buy: Here's Why
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zacks.com
- 3 weeks ago
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025
MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results.
globenewswire.com
- 3 weeks ago
Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025
MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025.
globenewswire.com
- 2 months ago
Balchem Is A Great Company, But I'm Still Waiting For A Better Entry
Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors.
seekingalpha.com
- 2 months ago
Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript
Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's Fourth Quarter and Full Year 2024 Earnings Call.
seekingalpha.com
- 2 months ago
Blachem (BCPC) Lags Q4 Earnings and Revenue Estimates
Blachem (BCPC) came out with quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.82 per share a year ago.
zacks.com
- 2 months ago
Balchem Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
MONTVALE, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal fourth quarter ended December 31, 2024.
globenewswire.com
- 2 months ago
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025
MONTVALE, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 21, 2025, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2024 results.
globenewswire.com
- 2 months ago
Balchem Corporation to Present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025
MONTVALE, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025.
globenewswire.com
- 3 months ago
Industrial Chemicals: 3 Stocks Poised for Growth in the New Year
The chemicals industry—companies creating chemicals used in industrial, commercial, and a variety of other applications—thrived for many years leading up to and including the COVID-19 pandemic. However, a recent report by McKinsey & Co. shows that the period since the end of the pandemic has brought a sharp reversal of this trend, with chemicals companies as a group achieving growth of under 2% per year since late 2022 while global indexes have increased 24% per year over the same period.
marketbeat.com
- 4 months ago
Are Basic Materials Stocks Lagging Balchem (BCPC) This Year?
Here is how Blachem (BCPC) and Fresnillo PLC (FNLPF) have performed compared to their sector so far this year.
zacks.com
- 4 months ago
Recent Price Trend in Blachem (BCPC) is Your Friend, Here's Why
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
zacks.com
- 4 months ago
8. Profile
Summary
Balchem Corporation BCPC
COUNTRY
US
INDUSTRY
Chemicals - Specialty
MARKET CAP
$ 5.14 B
Dividend Yield
0.00%
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Contact
52 Sunrise Park Road, New Hampton, NY, 10958
https://www.balchem.com
IPO
Date
June 3, 1986
Employees
1361
Officers
Mr. Theodore Lee Harris
Chief Executive Officer, President & Chairman
Mr. Martin Luther Reid
Senior Vice President & Chief Supply Chain Officer
Ms. Hatsuki Miyata J.D.
Executive Vice President, Chief Legal Officer & Secretary
Mr. Michael R. Sestrick Ph.D.
Senior Vice President & Chief Technology Officer
Mr. M. Brent Tignor
Senior Vice President & Chief Human Resources Officer
Mr. Jonathan H. Griffin
Senior Vice President of Corporate Development
Mr. Frederic Boned
Senior Vice President and GM of Human Nutrition & Health
Mr. Carl Martin Bengtsson
Executive Vice President, Chief Financial Officer, Treasurer and GM of Animal Nutrition & Health
Mr. William A. Backus CPA
Vice President & Chief Accounting Officer
Mr. Job L. van Gunsteren
Senior Vice President & GM of Specialty Products